NECLIFE
Invest Now

Nectar Lifesciences Share Price
₹23.54 -0.07 (-0.3%)
28 Mar, 2025 11:52
Start SIP in
NECLIFE
Performance
- Low
- ₹24
- High
- ₹25
- 52 Week Low
- ₹22
- 52 Week High
- ₹57
- Open Price₹24
- Previous Close₹24
- Volume1,293,430
Investment Returns
- Over 1 Month -12.87%
- Over 3 Month -39.23%
- Over 6 Month -42.15%
- Over 1 Year -21.26%
Smart Investing Starts Here Start SIP with Nectar Lifesciences for Steady Growth!
Nectar Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 31.1
- PEG Ratio
- 0.3
- Market Cap Cr
- 528
- P/B Ratio
- 0.5
- Average True Range
- 1.71
- EPS
- 0.76
- Dividend Yield
- 0
- MACD Signal
- -2.2
- RSI
- 37.59
- MFI
- 37.36
Nectar Lifesciences Financials
Nectar Lifesciences Technicals
EMA & SMA
Current Price
₹23.54
-0.07
(-0.3%)

-
- Bearish Moving Average 15
-
- Bullish Moving Average 1
- 20 Day
- ₹25.54
- 50 Day
- ₹29.32
- 100 Day
- ₹32.29
- 200 Day
- ₹33.58
Resistance and Support
23.38
- R3 25.76
- R2 24.89
- R1 24.25
- S1 22.74
- S2 21.87
- S3 21.23
Nectar Lifesciences Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-31 | Quarterly Results & Others | To consider other business matters. per share(5%)Final Dividend (BC dates revised) |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-15 | Audited Results | |
2024-02-14 | Quarterly Results |
Nectar Lifesciences F&O
About Nectar Lifesciences
- NSE Symbol
- NECLIFE
- BSE Symbol
- 532649
- Chairman & Managing Director
- Mr. Sanjiv Goyal
- ISIN
- INE023H01027
Similar Stocks to Nectar Lifesciences
Nectar Lifesciences FAQs
Nectar Lifesciences share price is ₹23 As on 28 March, 2025 | 11:38
The Market Cap of Nectar Lifesciences is ₹527.9 Cr As on 28 March, 2025 | 11:38
The P/E ratio of Nectar Lifesciences is 31.1 As on 28 March, 2025 | 11:38
The PB ratio of Nectar Lifesciences is 0.5 As on 28 March, 2025 | 11:38
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.